InvestorPlace - Stock Market News, Stock Advice & Trading Tips
GCT stock results show that GigaCloud Tech missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
The post GCT Stock Earnings: GigaCloud Tech Misses EPS, Beats Revenue for Q2 2024 appeared first on InvestorPlace.
More From InvestorPlace
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
HRTX stock results show that Heron Therapeutics missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
The post HRTX Stock Earnings: Heron Therapeutics Misses EPS, Beats Revenue for Q2 2024 appeared first on InvestorPlace.
More From InvestorPlace
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
XAIR stock results show that Beyond Air beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2025.
The post XAIR Stock Earnings: Beyond Air Beats EPS, Misses Revenue for Q1 2025 appeared first on InvestorPlace.
More From InvestorPlace
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
CART stock results show that Maplebear beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
The post CART Stock Earnings: Maplebear Beats EPS, Beats Revenue for Q2 2024 appeared first on InvestorPlace.
More From InvestorPlace
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
SGC stock results show that Superior Gr of Cos missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
The post SGC Stock Earnings: Superior Gr of Cos Misses EPS, Misses Revenue for Q2 2024 appeared first on InvestorPlace.
More From InvestorPlace
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
ATGE stock results show that Adtalem Glb Education beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2024.
The post ATGE Stock Earnings: Adtalem Glb Education Beats EPS, Beats Revenue for Q4 2024 appeared first on InvestorPlace.
More From InvestorPlace
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
VCYT stock results show that Veracyte beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
The post VCYT Stock Earnings: Veracyte Beats EPS, Beats Revenue for Q2 2024 appeared first on InvestorPlace.
More From InvestorPlace
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
PLUS stock results show that ePlus missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2025.
The post PLUS Stock Earnings: ePlus Misses EPS, Misses Revenue for Q1 2025 appeared first on InvestorPlace.
More From InvestorPlaceA dissolution will be a full circle for the political party, which replaced its predecessor after it was disbanded for breaching election rules in 2020.
HBM3E chips are likely to become the mainstream HBM product in the market this year
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
ADEA stock results show that Adeia beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
The post ADEA Stock Earnings: Adeia Beats EPS, Beats Revenue for Q2 2024 appeared first on InvestorPlace.
More From InvestorPlaceVice President Harris' campaign website doesn't include information about her planned economic policies or a platform roughly two weeks after becoming the presumptive nominee.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
STEM stock results show that Stem met analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
The post STEM Stock Earnings: Stem Meets EPS, Misses Revenue for Q2 2024 appeared first on InvestorPlace.
More From InvestorPlace
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
UTI stock results show that Universal Technical beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2024.
The post UTI Stock Earnings: Universal Technical Beats EPS, Beats Revenue for Q3 2024 appeared first on InvestorPlace.
More From InvestorPlace
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
TYGO stock results show that Tigo Energy missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
The post TYGO Stock Earnings: Tigo Energy Misses EPS, Misses Revenue for Q2 2024 appeared first on InvestorPlace.
More From InvestorPlace
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
SSTI stock results show that SoundThinking beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
The post SSTI Stock Earnings: SoundThinking Beats EPS, Beats Revenue for Q2 2024 appeared first on InvestorPlace.
More From InvestorPlace
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
TOST stock results show that Toast beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
The post TOST Stock Earnings: Toast Beats EPS, Beats Revenue for Q2 2024 appeared first on InvestorPlace.
More From InvestorPlaceFox News host Laura Ingraham reacts to Vice President Kamala Harris announcing Gov. Tim Walz, D-Minn., as her running mate on "The Ingraham Angle."
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
SLDP stock results show that Solid Power missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
The post SLDP Stock Earnings: Solid Power Misses EPS, Misses Revenue for Q2 2024 appeared first on InvestorPlace.
More From InvestorPlace
The Nevada Supreme Court will allow the state Board of Pharmacy to continue classifying marijuana as a Schedule I drug on par with heroin, in a reversal of a previous ruling.
In a ruling overturning a previous court decision, the Nevada Supreme Court moved to allow the state Board of Pharmacy to continue classifying cannabis as a Schedule I drug.
In a ruling overturning a previous court decision, the Nevada Supreme Court on Monday moved to allow the state Board of Pharmacy to continue classifying cannabis as a Schedule I drug.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
SWIM stock results show that Latham Group beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
The post SWIM Stock Earnings: Latham Group Beats EPS, Beats Revenue for Q2 2024 appeared first on InvestorPlace.
More From InvestorPlace